FDA Inspection 1110555 — Harry Earl Studdard, MD
The FDA completed an inspection of Harry Earl Studdard, MD on November 7, 2019 in Mobile, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 7, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Mobile, AL (United States)
Additional Details
Clinical Investigator (CI)